Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-30 · accession 0001567619-22-000372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-01-04 | 2021-12-30 | TXG | Kosaraju Sridhar | Dir | S - Sale | $150.38 | -1,500 | 3,000 | -33% | -$225.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-12-30 | S | D | 1,500 | $150.38 | 3,000 | I See footnote | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $150.00 to $150.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F3) These shares are held by the Kosaraju Family Trust. |